The Bitterest Plant
Is Also the Most Useful
Andrographis paniculata — eleven names, six civilisations, one conclusion
In 2024, researchers placed andrographolide head-to-head against four of the world’s most prescribed NSAIDs — aspirin, ibuprofen, paracetamol, and diclofenac — and measured each one at the NF-κB level: the master switch that controls the entire inflammatory cascade. The results were not ambiguous.
Andrographolide vs NSAIDs:
At the Master Inflammatory Switch
NF-κB is not one pathway among many. It is the central regulator that controls the production of IL-6, TNF-α, IFN-γ, and dozens of other inflammatory mediators simultaneously. When you inhibit NF-κB, you address systemic inflammation at the source — not just prostaglandin-mediated pain at the end of the chain.
The 2024 PLOS One study (Low et al.) measured IC50 values — the concentration required to inhibit 50% of NF-κB activation — for andrographolide and four NSAIDs directly:
At the mechanism level that actually drives systemic inflammation, andrographolide is approximately 20× more potent than the strongest NSAID tested. The other three don’t reach this target at all. The bitterest plant in the garden outperforms the drugs most people reach for first — not in folk tradition, but in a controlled laboratory comparison published in a peer-reviewed journal.
What the Evidence Shows
At the master inflammatory switch — the target NSAIDs barely reach.
Comparable clinical outcomes in mild cases at 180mg andrographolide/day.
7,175 patients. Andrographis consistently reduced severity and duration.
Comparable to table salt. Exceptional safety margin across traditional daily use.
Malaysia, India, China, Thailand, Tamil Nadu, and Scandinavia arrived at the same conclusion separately.
One of very few traditional plants granted formal government antiviral status.
Five Things That Reframe This Plant
The NSAIDs you take daily can’t reach NF-κB. Andrographolide does — at 20× lower concentration than the best one that can.
Aspirin, ibuprofen, and paracetamol work downstream on prostaglandins. Andrographolide works at the source of the entire inflammatory cascade. The mechanism difference is not a detail — it is the whole story.
Thailand’s government approved it by Cabinet decree as an antiviral — a status almost no traditional plant has achieved.
In July 2021, the Thai Cabinet officially approved andrographis extract (180mg andrographolide/day) for treating asymptomatic COVID-19 patients. Four subsequent RCTs reported outcomes comparable to favipiravir, an approved antiviral drug.
It modulates immunity bidirectionally — up when fighting infection, down when inflammation overshoots.
This dual-mode regulation — enhancing macrophage and T-lymphocyte activity during infection while simultaneously downregulating cytokine overproduction — is a pharmacological flexibility no pharmaceutical drug replicates.
The Orang Asli use for snakebite is not folklore — it maps directly to the compound’s anti-inflammatory and hepatoprotective mechanisms.
Snake venom causes systemic inflammation and liver damage. Andrographolide inhibits the inflammatory cascade and protects hepatocytes. The traditional application is pharmacologically precise.
Scandinavia independently discovered it for cold and flu — the same application as six Asian medical traditions.
European research programmes adopted andrographis for upper respiratory infections decades ago. ESCOP has formally approved it for URTIs. Six independent traditions arriving at the same application is not coincidence.
Every Name Reflects the Same Reverence
Andrographis paniculata has eleven names across six civilisations. Each name reflects the culture that found it, and none of them are the same — but every civilisation that found it kept it, built pharmacopoeia around it, and passed it down. The name changed. The conclusion did not.
“Bile of the earth.” Used by Malay communities and the Orang Asli Mah Meri tribe for fever, snakebite, diabetes, and hypertension. Traditional daily use for generations.
“King of Bitters.” Chief constituent of Ayurvedic, Siddha, and Unani formulations for liver disease, fever, and infection. Included in the Ayurvedic Pharmacopoeia of India.
“Thread piercing through the heart.” First recorded in Lingnan Caoyao Lu. TCM classification: cold, bitter; clears heat and resolves toxicity; enters lung, stomach, large intestine meridians.
“Sky above, earth below.” National List of Essential Medicines. Cabinet-approved 2021 for COVID-19 treatment. One of very few traditional plants with formal government antiviral status.
Classical Siddha medicine for fever, liver conditions, and infection. The Siddha tradition identified its bitter-cooling properties for systemic heat — anticipating the NF-κB and cytokine inhibition mechanism by centuries.
One of very few Asian herbs adopted into Scandinavian clinical herbal medicine. ESCOP approved for upper respiratory tract infections. Independent discovery of the same antiviral and anti-inflammatory application.
What Is Actually in the Plant
The bitterness of every part of Andrographis paniculata — leaves, roots, stems, seeds — is caused by its diterpene lactone compounds, concentrated throughout its tissues. The bitterness is the compound announcing itself. Over 50 compounds have been identified. Six compound classes drive the pharmacological story.
Andrographolide
Bicyclic diterpenoid lactone. NF-κB inhibitor at IC50 26.0 μM. The compound responsible for the bitterness and the majority of the pharmacological activity. Anti-inflammatory, antiviral, hepatoprotective, immunomodulatory, antidiabetic, antimicrobial, and anticancer properties documented.
Neoandrographolide
Contributes anti-inflammatory and anti-tumor activity independently of andrographolide. Works via different molecular targets — providing a synergistic effect when both compounds are present, as they are in the whole plant.
14-Deoxy-Andrographolide
Modulates andrographolide absorption and distribution. Present in whole-plant preparations but absent from many standardised andrographolide-only extracts — one reason whole-plant effects may differ from isolated compound effects.
30+ Flavonoids
Include andrographin, panicolin, and mono-O-methylwightin. Contribute antioxidant, anti-inflammatory, and hepatoprotective effects through pathways distinct from the diterpene lactones — broadening the plant’s therapeutic spectrum.
Xanthones (4 compounds)
Rare in the plant kingdom. Demonstrate direct hepatoprotective activity — protecting liver cells from toxin-induced damage. This supports the traditional use for liver conditions and validates the Orang Asli snakebite application at the compound level.
Noriridoids (5 compounds)
Found in very few plant species. Contribute to the plant’s distinctive bitter taste profile and antimicrobial properties. Current research is investigating their role in the overall synergistic pharmacological effect.
Three Studies That Matter
When Andrographolide Met the World’s Most Prescribed NSAIDs
Low et al. (2024, PLOS One) conducted the most direct comparison to date: andrographolide against aspirin, ibuprofen, paracetamol, and diclofenac at the NF-κB level. IC50 values measure potency — the lower the number, the more potent the compound at the target concentration.
Andrographolide: IC50 26.0 μM. Diclofenac: IC50 508.3 μM (inhibitory trend only). Aspirin, ibuprofen, and paracetamol: negligible or no NF-κB activity measured.
The same study measured cytokine inhibition across IL-6, TNF-α, and IFN-γ. Andrographolide demonstrated wide-spectrum inhibitory activity against all three. The NSAIDs demonstrated weak or no activity. This is not a comparison of natural vs synthetic — it is a comparison of two different mechanisms, and the NF-κB mechanism is upstream of the prostaglandin pathway the NSAIDs target.
Low et al. · PLOS One, 2024 · Direct Comparison: Andrographolide vs NSAIDs at NF-κB
When a Traditional Plant Went Head-to-Head with a Licensed Antiviral
In July 2021, the Thai Cabinet officially approved andrographis extract for treating asymptomatic COVID-19 patients — making it one of very few traditional plants to earn formal government antiviral status. The approval was based on a body of clinical evidence, not preclinical data.
Four randomised controlled trials subsequently compared andrographis extract (standardised to 180mg andrographolide/day) directly against favipiravir — an approved antiviral drug — in mild COVID-19 patients. All four reported comparable clinical and biomarker outcomes.
This is not a claim that andrographolide cures COVID-19. It is documentation that in four separate RCTs, a traditional plant extract produced outcomes comparable to a licensed antiviral drug in mild cases. That evidence base is what drove a government decision to place it on the National List of Essential Medicines.
Thai Cabinet Decree, July 2021 · Four RCTs — andrographolide vs favipiravir, mild COVID-19
The Mechanism That No Pharmaceutical Drug Replicates
Andrographolide does not simply suppress or stimulate immune function — it regulates it bidirectionally. During infection, it enhances macrophage activity, natural killer cell function, and T-lymphocyte proliferation — increasing the body’s capacity to eliminate pathogens. When immune response overshoots and causes inflammatory tissue damage, it simultaneously downregulates the cytokine cascade through NF-κB inhibition.
The Cochrane Collaboration’s systematic review of 33 trials with 7,175 patients found andrographis consistently reduced the severity and duration of upper respiratory tract infections compared to placebo and comparable to standard care in multiple contexts.
No pharmaceutical drug approved for infection or inflammation achieves bidirectional immune regulation. Immunosuppressants suppress. Antivirals block replication. Antibiotics kill bacteria. Andrographolide does something none of them do: it calibrates.
Cochrane Review — 33 trials, 7,175 patients, upper respiratory tract infections · Multiple studies on immunomodulation
Bile of the Earth: What Malaysia Knew That Modern Medicine Is Still Catching Up To
The Orang Asli Mah Meri tribe’s documented use of hempedu bumi for snakebite is not the most obvious application. It is, however, the most pharmacologically precise one. Snake venom causes two simultaneous crises: systemic inflammation and liver damage. Andrographolide directly addresses both — through NF-κB inhibition and through the xanthone-mediated hepatoprotective activity that several civilisations independently discovered.
In Malaysian traditional medicine, hempedu bumi appears in four distinct categories: fever management, blood sugar regulation, liver protection, and infection. These are not four different conditions demanding four different plants. They are four expressions of the same underlying pharmacological profile — the same compounds working through overlapping mechanisms on different systems.
The wrong default in Malaysia is treating hempedu bumi as an alternative to medicine. Thailand’s government placed it on the National List of Essential Medicines alongside aspirin, metformin, and metronidazole. That is not an alternative medicine list. That is medicine.
The plant grows wild across Malaysia. It requires no supply chain, no prescription, and no patent. The bitterness is the quality marker — the more bitter, the higher the andrographolide concentration. If your hempedu bumi supplement has no bitterness, it has no andrographolide. The taste is the test.
2,000 Years of Documentation
Ayurvedic and Siddha Documentation
Andrographis paniculata included in classical Ayurvedic texts as Kalmegh (“king of bitters”). Siddha tradition in Tamil Nadu identifies its bitter-cooling properties for systemic fever and liver conditions.
First Chinese Documentation
Recorded in Lingnan Caoyao Lu alongside 480 other herbs. TCM classification established: cold, bitter nature; enters lung, stomach, and large intestine meridians; clears heat and resolves toxicity.
Indian Pharmacopoeia Inclusion
Andrographis paniculata formally included in the Indian Pharmacopoeia — one of the earliest inclusions of a traditional plant in a national pharmacopoeia based on documented therapeutic use.
Andrographolide Isolated
The primary active compound, andrographolide, first isolated and characterised. Its bicyclic diterpenoid lactone structure identified. The compound responsible for the bitterness — and the pharmacology — now had a name.
Scandinavian Clinical Adoption
Swedish herbal medicine tradition formally adopts andrographis for cold and flu treatment. Independent European clinical research confirms anti-inflammatory and antiviral effects — arriving at the same conclusion as six Asian traditions.
NF-κB Mechanism Confirmed
Research establishes that andrographolide directly inhibits NF-κB — the master inflammatory switch. This explains the compound’s broad-spectrum anti-inflammatory activity and its effectiveness across multiple seemingly unrelated conditions.
Thai Government Antiviral Approval
Thai Cabinet officially approves andrographis extract for treating asymptomatic COVID-19 patients. Placed on National List of Essential Medicines. One of very few traditional plants to achieve formal government antiviral status anywhere in the world.
Direct Comparison Published
Low et al. (PLOS One) publish the first direct comparison of andrographolide against four NSAIDs at the NF-κB level. Andrographolide: IC50 26.0 μM. Diclofenac: IC50 508.3 μM. Aspirin, ibuprofen, paracetamol: negligible activity at this target.
Six Claims. Six Verdicts.
“Hempedu bumi is just an old Malay fever remedy with no scientific backing.”
A 2024 PLOS One study compared andrographolide directly against four of the world’s most prescribed NSAIDs at the NF-κB level — the master inflammatory switch. Andrographolide: IC50 26.0 μM. Diclofenac (the best-performing NSAID): IC50 508.3 μM. Aspirin, ibuprofen, paracetamol: negligible activity at this target. The Cochrane Collaboration reviewed 33 trials with 7,175 patients. Thailand’s Cabinet approved it as an antiviral by government decree. “No scientific backing” is one of the most inaccurate descriptions possible.
“The Orang Asli using hempedu bumi for snakebite was a lucky guess.”
Snake venom causes two simultaneous crises: systemic inflammation and acute liver damage. Andrographolide directly inhibits NF-κB — the master regulator of the inflammatory cascade. The xanthones in the plant demonstrate direct hepatoprotective activity, protecting liver cells from toxin-induced damage. The traditional snakebite application is not lucky — it is pharmacologically precise. The Orang Asli Mah Meri’s observation preceded the molecular biology by generations.
“Andrographolide is less effective than NSAIDs because it’s natural.”
“Natural” and “effective” are unrelated properties. The direct comparison at NF-κB shows andrographolide is approximately 20× more potent than diclofenac at this target, and the other NSAIDs can’t reach it at all. The reason NSAIDs are the default is not evidence of superior efficacy — it is evidence of superior marketing, patent protection, and prescription infrastructure. The efficacy comparison, at the actual mechanism level, does not favour the NSAIDs.
“Hempedu bumi is safe for everyone to take daily in high doses.”
The safety profile is excellent — LD50 greater than 5g/kg is comparable to table salt — but “safe for everyone” is an overclaim. Andrographolide is contraindicated in pregnancy (potential antifertility effects documented in animal studies). Long-term high-dose use requires monitoring. It has documented interactions with blood-thinning and antidiabetic medications due to pharmacological overlap. Traditional daily use in the Orang Asli community is well-documented; high-dose supplementation in modern contexts is a different category requiring individual assessment.
“Hempedu bumi only works for fever and colds.”
Fever and URTIs are where the evidence is strongest — but they are not the only applications documented. Clinical evidence exists for liver protection (hepatoprotection comparable to silymarin in some studies), blood sugar regulation (HbA1c and fasting glucose reduction), anti-inflammatory applications beyond infection, and antiviral activity against multiple pathogen types. The bidirectional immunomodulatory mechanism means the same compound is relevant to both infectious and inflammatory conditions simultaneously.
“The standardised extract is always superior to the whole plant.”
Standardised andrographolide extracts provide predictable dosing and have the strongest clinical evidence base. However, 14-deoxy-andrographolide and neoandrographolide — absent from many single-compound extracts — contribute independently to the pharmacological profile and may modulate andrographolide’s bioavailability. Traditional whole-plant preparations (fresh leaf, tea, tincture) deliver the full compound synergy that isolated extracts remove. Standardised is more reliable. Whole-plant is more complete. They are not equivalent, and neither is categorically superior in all contexts.
How to Use Hempedu Bumi
Four preparation methods — from traditional whole-plant use to standardised clinical dosing. The bitterness is the quality indicator: the stronger the bitter taste, the higher the andrographolide concentration. If it is not bitter, it has not been prepared correctly or the quality is poor.
Method: Wash 3–5 fresh leaves. Chew directly or blend with a small amount of water and drink.
Dose guide: Traditional Orang Asli use — consumed at onset of fever or illness.
Note: Intensely bitter. The bitterness confirms compound presence. Add honey if needed but do not eliminate the bitterness.
Method: Boil 10–15g dried leaves or 5–7 fresh leaves in 2 cups water. Reduce to 1 cup over 20 minutes. Strain and drink.
Dose guide: One cup twice daily during acute illness.
Note: The traditional preparation method. Extracts both andrographolide and the xanthone compounds into the water phase.
Method: Commercial capsules or tablets standardised to andrographolide content.
Dose guide: 200–400mg andrographolide daily for URTIs (clinical dosing). Thai Cabinet protocol: 180mg andrographolide daily.
Note: Most studied form. Look for “standardised to X% andrographolide.” Verify the andrographolide percentage on the label, not just the raw herb weight.
Method: Commercial alcohol-based tincture (1:5 ratio, 40–60% ethanol).
Dose guide: 2–4ml three times daily during acute illness.
Note: Alcohol extraction captures both diterpene lactones and flavonoids. Bitterness should be present in the tincture. Avoid if you have alcohol sensitivity.
The NF-κB comparison is laboratory-level: The 20× potency figure compares isolated compounds in cell-based assays. In vivo bioavailability, metabolism, and tissue distribution change the picture. Potency at a target in a lab dish does not translate directly to clinical superiority.
COVID-19 data is preliminary: The four RCTs comparing andrographolide to favipiravir are promising but represent mild cases in specific populations. This does not constitute evidence for severe COVID-19 treatment.
Pregnancy is a hard contraindication: Animal studies show antifertility effects. Andrographis paniculata should not be used during pregnancy or when trying to conceive.
Drug interactions require attention: Documented interactions with anticoagulants and antidiabetic medications. If you are on these medications, discuss with your healthcare provider before use.
Quality matters enormously: The andrographolide content of dried herb products varies widely. If your supplement or dried herb has no bitterness, the active compound content is likely negligible.
References & Sources ↓
- Low et al. (2024). Direct comparison of andrographolide vs NSAIDs at NF-κB. PLOS One. IC50 values: andrographolide 26.0 μM, diclofenac 508.3 μM.
- Thai Cabinet Decree (July 2021). Andrographis paniculata approved for asymptomatic COVID-19 treatment. National List of Essential Medicines, Thailand.
- Cochrane Systematic Review. Andrographis paniculata for upper respiratory tract infections: 33 trials, 7,175 patients. Consistent reduction in severity and duration.
- Four RCTs: Andrographis extract (180mg andrographolide/day) vs favipiravir in mild COVID-19. Comparable clinical and biomarker outcomes across all four trials.
- ESCOP (European Scientific Cooperative on Phytotherapy). Andrographis paniculata monograph — approved for symptomatic treatment of upper respiratory tract infections.
- Ayurvedic Pharmacopoeia of India. Formal inclusion of Andrographis paniculata (Kalmegh). Indian Pharmacopoeia, 1919 edition.
- Andrographolide acute oral toxicity: LD50 >5g/kg body weight in rat studies. Safety profile comparable to table salt.
- Hepatoprotective studies: Xanthone compounds in Andrographis paniculata — direct hepatocyte protection from toxin-induced damage.
- Orang Asli Mah Meri ethnobotanical records: Hempedu bumi use for fever, snakebite, diabetes, and hypertension — documented by ethnobotanical surveys of Malaysian indigenous communities.
- TCM classification: Lingnan Caoyao Lu — first Chinese documentation of Chuān Xīn Lián (穿心蓮). Meridian tropism and bitter-cold classification established.